Screener
Organogenesis Holdings Inc. ORGO Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $43.76M-56.7% | $37.23M-57.1% | $225.61M+78.1% | $150.86M+31.0% | $101.01M-22.4% | ||
| $18.3M+76.0% | $15.16M+42.5% | $10.29M-10.8% | $13.22M+27.8% | $10.4M-33.3% | ||
| $53.97M-26.9% | $65.19M-10.1% | $100.17M+35.6% | $79.74M+11.1% | $73.81M-3.6% | ||
| $94.75M-16.6% | $106.12M-6.5% | $162.32M+39.4% | $130.14M+19.5% | $113.58M-21.2% | ||
| $23.67M-14.3% | $25.77M+8.6% | $49.92M+60.8% | $36.25M+35.3% | $27.63M-5.4% | ||
| -$50.99M-305% | -$68.89M-158% | $63.29M— | $20.73M+232% | -$12.58M+9.5% | ||
| -116.5%-104pp | -185.1%-154pp | 28.1%— | 13.7%+8.3pp | -12.5%-1.8pp | ||
| -$138K+79.4% | -$380K+60.5% | -$236K— | -$415K-188% | -$669K-208% | ||
| $112K-84.9% | $418K-56.6% | $138K— | $433K+203% | $742K+215% | ||
| -$50.88M-330% | -$68.47M-166% | $63.43M— | $21.16M+263% | -$11.83M+18.6% | ||
| $45.39M+1,959% | -$15.32M-121% | $19.73M— | -$407K+93.7% | -$2.44M-198% | ||
| -$96.27M-925% | -$53.16M-182% | $43.7M+470% | $21.57M+74.9% | -$9.39M+44.9% | ||
| -220%-211pp | -142.8%-121pp | 19.4%+13.3pp | 14.3%+3.6pp | -9.3%+3.8pp | ||
| -$0.77-670% | -$0.44-159% | $0.27— | $0.11+22.2% | -$0.10+23.1% | ||
| -$47.32M-435% | -$64.72M-178% | $67.36M— | $24.76M+152% | -$8.84M+16.0% | ||
| -108.2%-99.4pp | -173.8%-147pp | 29.9%— | 16.4%+7.9pp | -8.8%-0.7pp | ||
| -$50.99M-305% | -$68.89M-158% | $63.29M— | $20.73M+232% | -$12.58M+9.5% |
FAQ
- What is Organogenesis Holdings Inc.'s revenue?
- Organogenesis Holdings Inc. (ORGO) generated $457.5M in revenue over the trailing twelve months, up 6.5% year over year.
- Is Organogenesis Holdings Inc. profitable?
- Organogenesis Holdings Inc. is not currently profitable: it reported a net loss of $84.2M over the trailing twelve months, a -18.4% net margin.
- What are Organogenesis Holdings Inc.'s profit margins?
- Gross margin is 75.9% and operating margin is -7.8%, with a -18.4% net margin.
- What is Organogenesis Holdings Inc.'s earnings per share?
- Organogenesis Holdings Inc.'s diluted EPS over the trailing twelve months is $-0.83.
- Where does Organogenesis Holdings Inc.'s income statement data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
